# Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage

> **NCT01787123** · PHASE2,PHASE3 · COMPLETED · sponsor: **Kwong Wah Hospital** · enrollment: 50 (actual)

## Conditions studied

- Subarachnoid Hemorrhage
- Intracranial Aneurysm
- Delayed Cerebral Ischemia
- Delayed Ischemic Neurological Deficit

## Interventions

- **DRUG:** Intravenous Cerebrolysin
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT01787123
- **Lead sponsor:** Kwong Wah Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-01
- **Primary completion:** 2019-01-01
- **Final completion:** 2019-01-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01787123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01787123, "Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT01787123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*